Related Experiment Videos

Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon

Y Gunji1, M Tagawa, H Matsubara

  • 1Department of Surgery (II), School of Medicine, Chiba University, Japan.

Cancer Letters
|March 29, 1996
PubMed

Insights

Cancer gene therapy using granulocyte macrophage-colony stimulating factor (GM-CSF) showed significant antitumor effects in mice. GM-CSF producing tumor cells prolonged survival and reduced tumor growth, indicating therapeutic potential.

Area of Science:

  • Oncology
  • Immunotherapy
  • Gene Therapy

Background:

  • Cytokines play a crucial role in immune responses and cancer development.
  • Retroviral transduction allows for the genetic modification of tumor cells to express specific cytokines.
  • Evaluating the in vivo efficacy of cytokine-engineered tumor cells is essential for cancer therapy development.

Purpose of the Study:

  • To investigate the antitumor effects of murine colon carcinoma cells engineered to secrete cytokines.
  • To compare the efficacy of granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-4 (IL-4), and interleukin-6 (IL-6) expression in vivo.
  • To assess the feasibility of GM-CSF gene therapy for colon carcinoma.

Main Methods:

  • Retroviral transduction of murine colon carcinoma cells with genes encoding GM-CSF, IL-4, or IL-6.
  • Inoculation of syngeneic mice with engineered tumor cells.
  • Monitoring of animal survival, tumor growth, and performing histological examinations.

Main Results:

  • Mice inoculated with GM-CSF-producing cells exhibited prolonged survival and reduced tumorigenicity.
  • IL-4-producing cells demonstrated a lesser antitumor effect compared to GM-CSF.
  • IL-6-producing cells did not significantly impact host survival.
  • Histological analysis of GM-CSF tumors revealed neutrophil infiltration and necrosis.

Conclusions:

  • GM-CSF expression in tumor cells confers significant antitumor effects in a murine model.
  • GM-CSF demonstrates superior efficacy over IL-4 and IL-6 in this context.
  • The study supports the feasibility of using GM-CSF gene therapy for colon carcinoma treatment.

Related Concept Videos